Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

US Patent 12054474 · Granted Aug 6, 2024

Estimated economic value: $38,159,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2022
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2022
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2022
MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or c2022
Piperidine derivatives for use in the treatment or prevention of psychiatric and2020
Piperidine derivatives for use in the treatment or prevention of psychiatric and2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2019
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors2019
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors2019